PPIs linked to increased risk of chronic kidney disease and progression to end-stage renal diseaseRisk of adverse renal outcomes increases with duration of PPI use beyond 30 days. Pharmacists can effectively screen at-risk patients for chronic kidney diseaseStudy provides evidence of the benefits of expanding community pharmacists’ scope to include lab test ordering. Cysview fluorescence cystoscopy improves bladder cancer detection An adjunct to white light cystoscopy for detecting nonmuscle invasive papillary bladder cancer. World Vasectomy Day cuts to heart of male responsibility for contraception Antibiotic prophylaxis for urologic procedures New Canadian guidelines clarify when prophylaxis is needed for specific urologic procedures. New Canadian guidelines for managing erectile dysfunction Use a stepwise treatment approach, once reversible causes are ruled out. Urologist message to Cancer Summit: Don’t blush men…just get your prostate checked Prophylactic antibiotics for children with recurrent urinary tract infections New statement provides recommendations for when to use prophylaxis, which drugs to use and duration of therapy. VIDEO: Dr. Mike Evans on the prostate specific antigen test Nocdurna sublingual tablets for nocturia in women Low-dose desmopressin formulation reduces number of voids, increases time to first void. First Previous 7 8 9 10 11 Next Last
